Eqvita

OptiThyDose is a digital health company focused on enhancing the lives of children and adults with chronic diseases, specifically managing hypothyroidism and hyperthyroidism. The company operates in the healthcare sector, providing solutions that require prompt and accurate medical treatment to protect cognitive and physiological development in children and improve the quality of life in adults. OptiThyDose's core product applies advanced decision support algorithms to optimize and personalize thyroid treatment, ensuring the balance of thyroid function is restored and maintained. The business model revolves around leveraging clinical and technical expertise to develop cutting-edge digital health solutions. Revenue is generated through the sale and implementation of these solutions in healthcare settings. The team comprises experts in clinical and technical fields, including Dr. Gilbert Koch as CEO, Dr. Delphine Geraud in business development, and Dr. Britta Steffens in product management, supported by software developers and clinical advisors. The company collaborates with renowned clinical advisors like Prof. Dr. Michel Polak, MD, PhD, to ensure the efficacy and reliability of its products.

Keywords: thyroid treatment, chronic diseases, digital health, decision support, personalized medicine, healthcare, algorithms, clinical expertise, pediatric endocrinology, quality of life.